Intellectual Property India Publishes Patent Application for 'Pluripotent Stem Cell-Derived Megakaryocytes And Platelets' Filed by Garuda Therapeutics, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517042244 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 1, for 'pluripotent stem cell-derived megakaryocytes and platelets.'

Inventor(s) include Shah, Dhvanit.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides for efficient ex vivo processes for generating megakaryocytes and/or platelets from human induced pluripotent stem cells (iPSCs). Cells and platelets generated according to the disclosure in various embodiments are functional and/or more closely resemble the corresponding lineage isolated from peripheral blood, bone marrow, or other tissues. The present invention in some aspects provides isolated cells/platelets and compositions produced by the methods disclosed herein, as well as methods for therapy."

The patent application was internationally filed on Oct. 05, 2023, under International application No.PCT/US2023/076102.

Disclaimer: Curated by HT Syndication.